BARON SILVER STEVENS FINANCIAL ADVISORS, LLC
Position in PFE — Pfizer Inc
CIK 1851395
Boca Raton, FL
Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$543,244
-$98,664 QoQ
Shares Held
22,560
-1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#1,696
of 2,821 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BARON SILVER STEVENS FINANCIAL ADVISORS, LLC holds $5,410,143 across 7 Drug Manufacturers - General names. PFE ranks #5 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,253 | $1,334,104 | |
| 2 | LLY |
ELI LILLY & Co
|
775 | $929,558 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
7,173 | $906,236 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,964 | $894,874 | |
| 5 | PFE |
Pfizer Inc
This page
|
22,560 | $543,244 | |
| 6 | ABBV |
AbbVie Inc.
|
1,986 | $499,757 | |
| 7 | AMGN |
Amgen Inc
|
835 | $302,370 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $543,244 | 22,560 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $641,908 | 22,860 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $569,214 | 22,860 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $611,188 | 23,987 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $237,891 | 9,814 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $239,995 | 9,471 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $250,416 | 9,439 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $274,958 | 9,501 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $277,673 | 9,924 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $340,548 | 12,272 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $339,578 | 11,795 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $501,928 | 15,132 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $527,971 | 14,394 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $579,931 | 14,214 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $742,980 | 14,500 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $643,447 | 14,704 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $876,262 | 16,713 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $765,678 | 14,790 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $744,089 | 12,601 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $503,475 | 11,706 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $482,647 | 12,325 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $416,681 | 11,501 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $386,541 | 10,501 | Shares | Sole | 2021-03-19 | |
| No filing history on record for this holder in this stock. | ||||||